A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Safety, Tolerability and Pharmacokinetic Study of Topical Pirenzepine in Healthy Volunteers
Latest Information Update: 16 Jul 2019
At a glance
- Drugs Pirenzepine (Primary)
- Indications Diabetic neuropathies
- Focus Adverse reactions; First in man
- Sponsors WinSanTor
- 17 Apr 2017 New trial record